Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AdaptHealth Corp (AHCO) vs C.H. Robinson Worldwide, Inc. (CHRW) Price & Performance

AdaptHealth Corp
C.H. Robinson Worldwide, Inc.

Price performance

Price movement over the last 24 hours

Key statistics

AdaptHealth Corp vs C.H. Robinson Worldwide, Inc. — how do they compare? AdaptHealth Corp trades at $10.05 (market cap $1.38B), while C.H. Robinson Worldwide, Inc. trades at $189.12 (market cap $22.49B). The key difference: C.H. Robinson Worldwide, Inc. is far larger — about 16.3× AdaptHealth Corp's market cap, and C.H. Robinson Worldwide, Inc. pays a 1.32% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.

AHCOCHRW
Market Cap
$1.38B$22.49B
Sector
HealthIndustrials
52-Week High
$13.38$200.59
52-Week Low
$8.68$96.82
Enterprise Value
$3.33B$23.98B
Dividend Yield
1.32%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AdaptHealth Corp

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

C.H. Robinson Worldwide, Inc.

CH Robinson Worldwide (CHRW) trades at $190.95, up 0.58% with a bullish technical outlook. The stock shows strong profitability with ROE of 34.84% and has beaten earnings estimates for three consecutive quarters. Recent acquisitions like DeSpir Logistics and AI technology launches position the company for growth in logistics efficiency. Valuation metrics appear elevated with P/E of 38.18, though revenue has declined from 2022 peaks to $16.23B in 2025.

The outlook remains positive with analyst consensus target of $198.83 representing 4% upside. Key opportunities include AI-driven supply chain optimization and industry consolidation benefits, while risks involve freight market volatility and competitive pressures. Cash flow generation remains healthy with $915M operating cash flow in 2025 supporting dividend payments.

Returns comparison

Trailing returns across standard periods

About AdaptHealth Corp

AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.

Read more on AHCO

About C.H. Robinson Worldwide, Inc.

C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (57% of 2021 net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm also operates a large air and ocean forwarding division (34%), which has grown organically and via tuck-in acquisitions. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.

Read more on CHRW